- Home
- XTKG vs KZR Comparison
XTKG vs KZR Comparison
Compare XTKG & KZR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XTKG
- KZR
- Stock Information
- Founded
- XTKG 1997
- KZR 2015
- Country
- XTKG Singapore
- KZR United States
- Employees
- XTKG N/A
- KZR N/A
- Industry
- XTKG
- KZR Biotechnology: Pharmaceutical Preparations
- Sector
- XTKG
- KZR Health Care
- Exchange
- XTKG NYSE
- KZR Nasdaq
- Market Cap
- XTKG 53.6M
- KZR 54.1M
- IPO Year
- XTKG 2019
- KZR 2018
- Fundamental
- Price
- XTKG $0.77
- KZR $6.25
- Analyst Decision
- XTKG
- KZR Hold
- Analyst Count
- XTKG 0
- KZR 2
- Target Price
- XTKG N/A
- KZR $11.00
- AVG Volume (30 Days)
- XTKG 299.8K
- KZR 61.0K
- Earning Date
- XTKG 12-27-2024
- KZR 11-12-2024
- Dividend Yield
- XTKG N/A
- KZR N/A
- EPS Growth
- XTKG N/A
- KZR N/A
- EPS
- XTKG N/A
- KZR N/A
- Revenue
- XTKG $15,234,138.00
- KZR N/A
- Revenue This Year
- XTKG N/A
- KZR N/A
- Revenue Next Year
- XTKG N/A
- KZR N/A
- P/E Ratio
- XTKG N/A
- KZR N/A
- Revenue Growth
- XTKG 51.59
- KZR N/A
- 52 Week Low
- XTKG $0.08
- KZR $5.20
- 52 Week High
- XTKG $2.14
- KZR $11.40
- Technical
- Relative Strength Index (RSI)
- XTKG 46.05
- KZR 28.75
- Support Level
- XTKG $0.66
- KZR $6.80
- Resistance Level
- XTKG $1.34
- KZR $7.04
- Average True Range (ATR)
- XTKG 0.21
- KZR 0.24
- MACD
- XTKG -0.10
- KZR -0.06
- Stochastic Oscillator
- XTKG 5.71
- KZR 0.00
About XTKG X3 HOLDINGS CO LTD
X3 Holdings Co Ltd is company which is responsible for globally providing of Technology Solutions and Services across Diverse Industries that operates across four business segments: digital technologies, renewable energy, Cryptomining Operations, and agriculture technologies.
About KZR Kezar Life Sciences Inc.
Kezar Life Sciences Inc is a clinical-stage biotechnology company. It is engaged in discovering and developing novel small molecule therapeutics to treat unmet needs in autoimmunity and cancer. The pipeline consist of product candidates such as Zetomipzomib (KZR-616), and KZR-261.